Ruby Lin
Adjunct A/Prof
PhD/MSc (Hons)/BSc
Ruby.lin@wimr.org.au

Biography
Ruby Lin is an accomplished executive leader with over 25 years of experience in life sciences, biotechnology, and translational research. She has secured over AUD$17 million in funding, focusing on genomic medicine’s translation into clinical practice.
A passionate advocate for women in STEMM, Ruby mentors students and scientists, and contributes to various initiatives, including serving as the Genomic Chair for Westmead Research Precinct, holds executive roles in the Australasian Genomic Technologies Association and an independent school in NSW. Her expertise encompasses genomics, cardiovascular disease, cancer biology, and infectious diseases with more than 120 high-impact publications. Ruby actively engages in community service, including mentoring and pro bono career coaching, while also serving on several scientific journal editorial boards.
Research interests
Phage therapy, Translational research, Human transcriptomics, Clinical Genomics, Systems Biology
Adjunct roles
Adjunct Professor | University of New South Wales |
Adjunct Professor | University of Sydney |
Recent publications

Phage Biobank: Present Challenges and Future Perspectives. Current Opinions in Biotechnology

Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child.

Safety of bacteriophage therapy in severe Staphylococcus aureus infection.

Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial.

Reduced PI3K induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation.
Additional information
ORCID: 0000-0003-4163-511X
Google Scholar: https://scholar.google.com.au/citations?hl=en&user=toGeB14AAAAJ&view_op=list_works&sortby=pubdate
Current grants
NSW Statewide Biobanking Initiative | 2019-2022 | Pathogen & Phage Biobanks at Westmead |
MRFF Frontiers Stage 1 | 2021-2022 | JI and Phage Australia network. |
Office of Health and Medical Research | 2022 | Australia: Education package for phage therapy (RL) |
Office of Health and Medical Research | 2023-2025 | Australia: Securing sovereign manufacturing of phages in NSW |
Hooper Shaw Foundation | 2023-2026 | AMR: bioprospecting and co-evolution. JI. |
Affiliations
Westmead Hospital, University of Sydney
Professional Associations and Organisations
2003 to date | Australasian Genomic Technologies Association | Executive |
2021-2023 | Association of Australian Meical Research Institute | Gender Equality, Diversity and Inclusion Committee member |
2016 to date | Science and Technology Australia | AGTA member |
2021 to date | European Society of Clinical Microbiology & Infectious Diseases | |
2020 to date | International Society for Viruses of Microorganisms | Member, Conference Convenor for Virus of Microbes 2023 |
2018 to date | Scientific Advisory Committee for Biobanking at Westmead Health Precinct | Member |
2018 to date | Scientific Advisory Committee for Bioinformatics at Westmead Health Precinct | Member |
2018 to date | Scientific Advisory Committee for Genomics at Westmead Health Precinct | Chair since 2019 |
2023 to date | Board of Directors, Hills Grammar School | Executive member and Chair of DGR |
Awards and recognition
2006-2009 NHMRC Peter Doherty Fellow |
2010 - 2014 UNSW Vice-Chancellor Global Postdoctoral Fellow |
2013-2015 President of AGTA |
2020 to date Deputy Director of Phage Australia |